 |
|
Loss of Teeth With Antidepressant Drug Therapy
Jerome A. Winer, MD;
Saul Bahn, MD
Arch Gen Psychiatry. 1967;16(2):239-240.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
DESPITE the plethora of published material concerning side effects of psychopharmacologic agents, only passing attention has been given to dryness of the mouth. This common, often distressing, but frequently unheeded complaint is well-known to occur with antidepressant and phenothiazine treatment.1 It has recently been shown to be associated with oral moniliasis in patients treated with chlorpromazine.2-4 In a large-scale investigation of 3,000 psychiatric patients who had recently received phenothiazines or antidepressants (imipramine hydrochloride) [Tofranil] and amitriptyline [Elavil], or both, 48% of the patients had oral cultures positive for monilia and 29.5% had actual clinical lesions.5 Quantitative measurement has shown that salivary flow decreases with chlorpromazine administration. This finding has been reported, with a warning to the dental profession to watch for subsequent complications.6
The case to be reported in this paper describes
. . . [Full Text PDF of this Article]
Author Affiliations
New Haven, Conn; West Haven, Conn
From the Department of Psychiatry, Yale University School of Medicine. New Haven, Conn (Dr. Winer) and the Department of Oral Surgery, Veterans Administration Hospital, West Haven, Conn (Dr. Bahn).
Footnotes
Submitted for publication July 29, 1966.
Reprint requests to Yale University School of Medicine, 333 Cedar St, New Haven, Conn 06511 (Dr. Winer).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
